Utenpanium chloride

N/A

Report date: 2026/02/20 20:02:00
NME

Base Information

Drug NameUtenpanium chloride
Drug Alias NameTapencariumRZL-012RZL-12MTK-012JS-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipolysis modulators
TargetsNot applicable
Therapy Area/IndicationsLocalized submental fatOverweightWeight Loss +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesRaziel Therapeutics Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLocalized submental fat
Inactive IndicationsOverweightWeight LossObesity +[5

Other Information

ATC CodeN/A
Related LinksN/A